BIO-TECHNE CORP. DL-,01/ US09073M1045 /
2024-08-30 8:08:16 AM | Chg. +3.50 | Volume | Bid10:56:09 AM | Ask10:56:09 AM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
67.00EUR | +5.51% | 0 Turnover: 0.00 |
67.00Bid Size: 83 | 68.50Ask Size: 81 | 2.65 bill.EUR | - | - |
Assets
|
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | 145.3000 | 154 | 176.8000 | 207.9000 | 223.2000 | ||||||
Intangible Assets | 446.3000 | 579.4000 | 516.5000 | 616 | 531.5000 | ||||||
Long-Term Investments | - | - | - | - | - | ||||||
Fixed Assets | - | - | - | - | - | ||||||
Inventories | 85.6000 | 91.1000 | 103.2000 | 116.7000 | 141.1000 | ||||||
Accounts Receivable | 120.3000 | 137.5000 | 122.5000 | 145.4000 | 194.5000 | ||||||
Cash and Cash Equivalents | 122 | 100.9000 | 146.6000 | 199.1000 | 172.6000 | ||||||
Current Assets | 398.4000 | 412.6000 | 520.9000 | 510.6000 | 605.6000 | ||||||
Total Assets | 1,593.2000 | 1,884.4000 | 2,027.6000 | 2,263 | 2,294.8000 |
Liabilities
|
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | 18.5000 | 16.2000 | 23.1000 | 29.4000 | 33.9000 | ||||||
Long-term debt | - | - | - | - | - | ||||||
Liabilities to Banks | - | - | - | - | - | ||||||
Provisions | 86.3000 | 89.8000 | 101.1000 | 93.1000 | 99 | ||||||
Liabilities | 514.1000 | 718.8000 | 646.4000 | 691.8000 | 593.8000 | ||||||
Share Capital | - | - | - | - | - | ||||||
Total Equity | 1,079.1000 | 1,165.6000 | 1,381.2000 | 1,571.2000 | 1,701 | ||||||
Minority Interests | 0.0000 | 0.0000 | 0.0000 | 8.3000 | -.8000 | ||||||
Total liabilities equity | 1,593.2000 | 1,884.4000 | 2,027.6000 | 2,263 | 2,294.8000 |
Income Statement
|
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 643 | 714 | 738.7000 | 931 | 1,105.6000 | ||||||
Depreciation (total) | - | - | - | - | - | ||||||
Operating Result | 136.2000 | 146.7000 | 157.4000 | 237.3000 | 296.6000 | ||||||
Interest Income | -9.8000 | -21.1000 | -18.6000 | -13.5000 | -10.5000 | ||||||
Income Before Taxes | 126 | 112 | 276.5000 | 148.2000 | 301.4000 | ||||||
Income Taxes | -.2000 | 15.9000 | 47.2000 | 8.6000 | 38.3000 | ||||||
Minority Interests Profit | 0.0000 | 0.0000 | 0.0000 | .8000 | 9 | ||||||
Net Income | 126.2000 | 96.1000 | 229.3000 | 140.4000 | 272.1000 |
Per Share
Cash Flow
|
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | 170.4000 | 181.6000 | 205.2000 | 352.2000 | 325.3000 | ||||||
Cash Flow from Investing Activities | -38.7000 | -336.8000 | 27.1000 | -243.5000 | -96.9000 | ||||||
Cash Flow from Financing | -99.2000 | 134.4000 | -183.8000 | -62.6000 | -242.9000 | ||||||
Decrease / Increase in Cash | 30.4000 | -21.1000 | 45.7000 | 52.5000 | -26.5000 | ||||||
Employees | 2,000 | 2,250 | 2,300 | 2,000 | 3,000 |